Measured Wealth Private Client Group, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1720235
PORTSMOUTH, NH
Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$23,595
+$5,152 QoQ
Shares Held
140
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#657
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Measured Wealth Private Client Group, LLC holds $841,832 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (2.8% of the industry book) .
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,595 | 140 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $18,443 | 140 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $19,856 | 140 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $19,653 | 140 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||